Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to $1.5 million.

  • Standard Biotools' Depreciation & Amortization (CF) fell 5166.83% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.1 million, marking a year-over-year increase of 601.09%. This contributed to the annual value of $12.5 million for FY2024, which is 21444.72% up from last year.
  • Latest data reveals that Standard Biotools reported Depreciation & Amortization (CF) of $1.5 million as of Q3 2025, which was down 5166.83% from $3.2 million recorded in Q2 2025.
  • Standard Biotools' Depreciation & Amortization (CF)'s 5-year high stood at $5.0 million during Q2 2021, with a 5-year trough of -$5.3 million in Q4 2021.
  • Over the past 5 years, Standard Biotools' median Depreciation & Amortization (CF) value was $1.2 million (recorded in 2023), while the average stood at $1.7 million.
  • Data for Standard Biotools' Depreciation & Amortization (CF) shows a peak YoY increase of 44448.05% (in 2021) and a maximum YoY decrease of 61569.2% (in 2021) over the last 5 years.
  • Over the past 5 years, Standard Biotools' Depreciation & Amortization (CF) (Quarter) stood at -$5.3 million in 2021, then soared by 115.48% to $819000.0 in 2022, then skyrocketed by 35.04% to $1.1 million in 2023, then surged by 183.91% to $3.1 million in 2024, then tumbled by 51.56% to $1.5 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $1.5 million for Q3 2025, versus $3.2 million for Q2 2025 and $3.3 million for Q1 2025.